Emerging growth biotechnology companies are increasingly pursuing alternative financing such as equity crowdfunding to advance their drug development programs.
In this new ShareVault white paper, Scott Jordan:
- Provides an overview of crowdfunding and details about the JOBS Act
- Describes the types of funding platforms
- Assesses the viability of crowdfunding as a source of revenue for life science companies, including seed, bridge and side car financings
To download the white paper please click, http://sjordanassociates.com/how-equity-crowdfunding-can-help-life-science-companies/
For learn more about raising capital via Crowdfunding portals, please visit HealthiosXchange, http://www.healthiosxchange.com/
2014 has been an exciting year for HealthiosXchange! Major milestones include:
✔ Member Growth - Surpassed 2,500 members as of August of 2014 (one year since launch)
✔ Partnerships - Launched a joint venture with PENSCO, a leading custodian of self-directed IRA capital
✔ Events - Launched next-generation “Events” platform to assist H/X member companies engage with Accredited investors online (webinars) and offline (road shows) including a “Ratings & Review” crowdsourced scoring platform
✔ Advanced Member Directory - Companies can easily identify Accredited and investment professionals (venture capitalists) in relation to their geo-location and investment preferences and communicate with them via a security encrypted interface
✔ Investor Syndicates (~Online Venture Funds), The Champion’s Program – H/X launched five investor syndicates including one for a prominent angel group, HealthTech Capital
✔ University/Tech Transfer – Dedicated market directory for University/Tech Transfer-based companies seeking “seed” capital from alternative investors
✔ Broker Dealer/RIA’s – Launched novel platform (“Aggregators”) for engaging with investment advisers and broker dealers including access to premium deal flow,due diligence tools (scoring), ability to diversify private equity portfolios via investor syndicates (~MicroVC’s),transparent reporting, and investing retirement capital (self-directed IRA’s) on behalf of clients.
Upcoming Milestones
✔ Strategic Sponsorship of Market Sectors – H/X is collaborating with leading Strategics (~Big Pharma) to “open access to innovation” including gaining first mover advantage on “Trending” companies
✔ Notifications - “Followers” of company pages receive catalyst updates in real time
✔ JOBS Module – A vibrant marketplace for companies to identify promising candidate and for prospects to monitor and engage with “Trending” companies
Please join HealthiosXchange by clicking http://www.healthiosxchange.com/signup?ref=3